[{"AccountsPayableCurrent_0_Q1_USD":1207700000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":3700000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":11200000.0,"AccruedIncomeTaxesNoncurrent_0_Q1_USD":3621900000.0,"DebtCurrent_0_Q1_USD":3248000000.0,"ProceedsFromPaymentsForOtherFinancingActivities_1_Q1_USD":-194400000.0,"LongTermInvestments_0_Q1_USD":2148700000.0,"OtherReceivablesNetCurrent_0_Q1_USD":1246400000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":1873000000.0,"IncomeLossFromContinuingOperationsPerDilutedShare_1_Q1_USD":1.6,"IncomeLossFromContinuingOperationsPerBasicShare_1_Q1_USD":1.6,"GainLossOnSaleOfBusiness_1_Q1_USD":0.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":517800000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":565800000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":7766700000.0,"OtherLiabilitiesCurrent_0_Q1_USD":2217400000.0,"ShortTermInvestments_0_Q1_USD":78400000.0,"PaymentsToAcquireProductiveAssets_1_Q1_USD":258300000.0,"PaymentsOfDividends_1_Q1_USD":671300000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":1699000000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q1_USD":73300000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_0_Q1_USD":127200000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q1_USD":240300000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_0_Q1_USD":77000000.0,"ProceedsFromShortTermDebt_1_Q1_USD":1748700000.0,"PaymentsForProceedsFromOtherInvestingActivities_1_Q1_USD":-51400000.0,"AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureOtherPercentageOfNonperformingAssets_1_Q1_pure":0.96,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-638500000.0,"CommonStockSharesHeldInEmployeeTrust_0_Q1_USD":3013200000.0,"StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0_Q1_USD":1000000000.0,"SeveranceCosts1_1_Q1_USD":9800000.0,"RestructuringSettlementAndImpairmentProvisions_1_Q1_USD":59900000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1_Q1_USD":-80500000.0,"ProceedsFromSaleOfShortTermInvestments_1_Q1_USD":36800000.0,"ProceedsFromSaleOfLongtermInvestments_1_Q1_USD":54500000.0,"PensionContributions_1_Q1_USD":15000000.0,"PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_0_Q1_USD":3632000000.0,"PaymentsToAcquireShortTermInvestments_1_Q1_USD":0.0,"PaymentsToAcquireLongtermInvestments_1_Q1_USD":83000000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_1_Q1_USD":849300000.0,"OtherOperatingActivitiesCashFlowStatement_1_Q1_USD":-74900000.0,"OtherComprehensiveIncomeLossTax_1_Q1_USD":-27200000.0,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1_Q1_USD":-442800000.0,"NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_1_Q1_USD":-44600000.0,"InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_0_Q1_USD":-16400000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_1_Q1_USD":1408100000.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_1_Q1_USD":0.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_1_Q1_USD":0.0,"EquitySecuritiesFvNiGainLoss_1_Q1_USD":164700000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-66700000.0,"DividendsPayableCurrent_0_Q1_USD":0.0,"DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_0_Q1_USD":15000000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q1_USD":63800000.0,"ContractWithCustomerLiability_0_Q1_USD":307800000.0,"TreasuryStockValue_0_Q1_USD":55700000.0,"TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_0_Q1_USD":687000000.0,"IncreaseDecreaseInDeferredIncomeTaxes_1_Q1_USD":-11200000.0,"RepaymentsOfLongTermDebt_1_Q1_USD":276300000.0,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":500000000.0,"InterestExpense_1_Q1_USD":92500000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"StockholdersEquity_0_Q1_USD":3078800000.0,"Revenues_1_Q1_USD":5859800000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":5879400000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":7897900000.0,"NetIncomeLoss_1_Q1_USD":1456500000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":382400000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-1060900000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":106700000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":1392100000.0,"LiabilitiesNoncurrent_0_Q1_USD":25295400000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":41102800000.0,"InventoryNet_0_Q1_USD":3102400000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":223400000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":1679900000.0,"CommonStockValue_0_Q1_USD":598100000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":1699000000.0,"AssetsCurrent_0_Q1_USD":13994200000.0,"Assets_0_Q1_USD":41102800000.0,"AssetImpairmentCharges_1_Q1_USD":50100000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-6885900000.0,"AccountsReceivableNetCurrent_0_Q1_USD":5106100000.0,"LiabilitiesCurrent_0_Q1_USD":12610200000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":1549600000.0,"ShareBasedCompensation_1_Q1_USD":71800000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":911700000.0,"ProceedsFromIssuanceOfLongTermDebt_1_Q1_USD":0.0,"InvestmentIncomeInterest_1_Q1_USD":14300000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":273600000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":2471600000.0,"TaxesPayableCurrent_0_Q1_USD":667400000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-362300000.0,"IncomeLossFromDiscontinuedOperationsNetOfTax_1_Q1_USD":0.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":1094200000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":6556100000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":908200000.0,"OtherAssetsNoncurrent_0_Q1_USD":3044600000.0,"NonoperatingIncomeExpense_1_Q1_USD":89100000.0,"MinorityInterest_0_Q1_USD":118400000.0,"LongTermDebtNoncurrent_0_Q1_USD":13982300000.0,"IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":1456500000.0,"Goodwill_0_Q1_USD":3779100000.0,"EarningsPerShareBasic_1_Q1_USD":1.6,"CostOfGoodsAndServicesSold_1_Q1_USD":1215100000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":3197200000.0,"PrepaidExpenseCurrent_0_Q1_USD":2761900000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":122700000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.133,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":2186200000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":23700000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":9141500000.0,"EarningsPerShareDiluted_1_Q1_USD":1.6,"TranslationAdjustmentForNetInvestmentHedgeNetOfTax_0_Q1_USD":4020000000.0,"Ticker":"LLY","CIK":"59478","name":"ELI LILLY & CO","OfficialName":"Eli Lilly and Company Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"282856619893.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20200501"}]